Latest Endo Pharmaceuticals Stories
NEWARK, Calif., Aug. 4, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced the appointment of R. Scott Shively, as Chief Commercial Officer and Senior Vice President. Mr.
DUBLIN, June 2, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that its Endo Pharmaceuticals subsidiary has completed the sale of its branded pharmaceutical
BUNAVAIL PDUFA date June 7, 2014; Pre-launch activities underway to support an anticipated late Q3 2014 launch RALEIGH, N.C., May 8, 2014 /PRNewswire/ -- BioDelivery Sciences International,
TAIPEI, April 23, 2014 /PRNewswire/ -- TWi Pharmaceuticals, Inc. today announced that it has entered into a settlement agreement with Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd.
PITTSBURGH, April 11, 2014 /PRNewswire/ -- Mylan Inc.
Campaign with Endo Pharmaceuticals and HealthyWomen Encourages Osteoarthritis Joint Pain Sufferers to ‘Get Up and Get Active’ DUBLIN (PRWEB) April 09, 2014
Campaign with Endo Pharmaceuticals and HealthyWomen Encourages Osteoarthritis Joint Pain Sufferers to 'Get Up and Get Active' DUBLIN, April 9, 2014 /PRNewswire/ -- Emmy-nominated choreographer,
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, April 9, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts'
BUNAVAIL PDUFA date June 7, 2014; Plans underway for potential Q3 2014 launch RALEIGH, N.C., March 14, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc.
MALVERN, Pa., Feb.
- An armed gangster.